Optogenetics and mRNA Vaccines Net Lasker Awards

This year’s winners are Dieter Oesterhelt, Peter Hegemann, Karl Deisseroth, Drew Weissman, Katalin Karikó, and David Baltimore.

Written byAnnie Melchor
| 2 min read
cartoon image showing colorful collection of syringes, coronavirus particles, and mrna to represent the vaccine development

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, DRAFTER123

The Lasker Foundation announced today (September 24) the recipients of their 2021 awards, which are often called “America’s Nobels.”

The 2021 Albert Lasker Basic Medical Research Award went to Dieter Oesterhelt (Emeritus, Max Planck Institute of Biochemistry), Peter Hegemann (Humboldt University of Berlin), and Karl Deisseroth (Stanford University) for their work on light-sensitive proteins known as opsins, and adapting that discovery into the field of optogenetics, which has led to new discoveries in neuroscience.

“Progress in science to some extent depends upon risky decisions of individuals. At times the results of these decisions can only be appreciated later in one’s career,” Hegemann said in his acceptance speech. “Together, we shared both the patience and the joy that comes from working in wild unexplored territories in order to bring discoveries about tiny proteins found in bacteria and algae to unexpected applications.”

The 2021 Lasker~Debakey Clinical Medical Research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • black and white photograph of stephanie melchor

    Stephanie "Annie" Melchor got her PhD from the University of Virginia in 2020, studying how the immune response to the parasite Toxoplasma gondii leads to muscle wasting and tissue scarring in mice. While she is still an ardent immunology fangirl, she left the bench to become a science writer and received her master’s degree in science communication from the University of California, Santa Cruz, in 2021. You can check out more of her work here.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies